Novel Central Catheter Eliminates Bloodstream Infections

A new peripherally inserted central catheter (PICC) helps clinicians attain and sustain zero central line-associated bloodstream infections.

The ArrowEVOLUTION with Chlorag+ard antimicrobial technology is a chlorhexidine-treated PICC that provides broad-spectrum antimicrobial protection both intra- and extra-luminally, with proven 99.99% colonization reduction of Gram-positive bacteria, Gram-negative bacteria, and fungi for at least 30 days. The ArrowEVOLUTION PICC is equipped with the Arrow Blue FlexTip, a nontapered tip designed to reduce risk of vessel occlusion, minimize vessel trauma, clear visualization under fluoroscopy and X-ray, and allow staggered exit sites to reduce the risk of incompatible medications mixing and forming precipitates in the central line.


Chlorag+ard offers 4-log reduction in colonization of microbes and fungi, including pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Candida albicans, and Acinetobacter baumannii, all known to cause central line associated bloodstream infections (CLABSIs). The ArrowEVOLUTION PICC provides an initial burst of chlorhexidine immediately after insertion to protect the subcutaneous tract; the Chlorag+ard coating continues to release chlorhexidine for at least 30 days, resulting in a 99.99% colonization reduction. The ArrowEVOLUTION PICC is a product of Teleflex (Limerick, PA, USA), and is available in an ergonomically designed maximal barrier precautions tray that supports adherence to most widely accepted guidelines.

"We … have developed the first chlorhexidine-based technology designed specifically to protect PICC catheter surfaces for at least 30 days from the pathogens that cause central line associated bloodstream infections,” said Jeff Black, Chairman and CEO of Teleflex. "We are excited about bringing this new technology option to hospitals striving to improve outcomes and attain and sustain zero CLABSIs, a major contributor to healthcare-acquired infections.”

The pressure injectable ArrowEVOLUTION PICC is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, blood sampling, infusion, pressure injection of contrast media and it allows for central venous pressure monitoring. The maximum pressure of the power injector equipment used must not exceed 2068 kPa.

Related Links:
Teleflex